The U.S. Supreme Court has declined to hear petitions from six major drugmakers challenging the Medicare Drug Price Negotiation Program, leaving in place lower court rulings that upheld the program ...

President Donald Trump disclosed stock purchases worth as much as $680,000 in Eli Lilly & Co. LLY earlier this year, with the ...

The U.S. Supreme Court declined to hear a pharmaceutical industry challenge to a plan to curb Medicare drug prices.

The Supreme Court declined to hear challenges from drugmakers fighting Medicare-negotatioed price reductions. Amazon hit with ...

The U.S. Supreme Court on Monday declined to hear a pharmaceutical industry challenge to the Medicare drug price negotiation ...

The U.S. Supreme Court turned away appeals from six pharmaceutical companies seeking to topple the Medicare drug price negotiation program that’s led to billions of dollars in discounts on topselling ...

Pharmaceutical companies are trying to prevent Medicare from negotiating discounts for drugs. Their legal challenges have ...

Presented by Coalition to Strengthen America’s Healthcare{beacon} View Online Health Care Health Care PRESENTED BY The Big ...

AARP and other consumer groups are hailing the Supreme Court’s decision that continues the cost-cutting, money-saving ...

The US Supreme Court turned away appeals from six pharmaceutical companies seeking to topple the Medicare drug price ...

Even as a new drug pricing specter rears its head in President Donald Trump’s “Most Favored Nation” policies, drugmakers ...

The Supreme Court on Monday dealt a major blow to the brand drug industry’s legal campaign against the Medicare drug price ...